Zepbound's evidence comes from SURMOUNT-1, also published in NEJM (Jastreboff et al., 2022)
Structurally it is built on a GIP-analogue backbone rather than a GLP-1 backbone, with substitutions at the positions governing receptor selectivity and a fatty diacid chain attached to enable albumin binding
The findings provide crucial data, according to the researchers, to inform ongoing discussions about balancing the sustainability of health care spending against improving accessibility and affordability of GLP-1 RA medications moving forward. The trend directly informs current debates surrounding insurance coverage policies for weight-loss treatments, highlighting the challenge of reconciling costs with clinical demand and benefit
Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
Hers: Best Women-Focused Platform With Brand-Name Wegovy Access Hers is the most-marketed GLP-1 program in our ranking and the one with the most confusing regulatory history
More serious but rare side effects include pancreatitis, kidney issues, allergic reactions, and possible thyroid tumors (seen in animal studies)